A Multiple Dose Opioid Challenge Study

Clinical trial NCT02611752 · COMPLETED

Trial details

NCT number: NCT02611752
Sponsor: Braeburn Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Moderate or Severe Opioid Use Disorder

Start date: 2015-10-01
Primary completion: 2016-04-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.